Media Coverage

Because trust plays a big part in customers' decisions about what to buy, employees' decisions about where to work and investors decisions about whether to invest, Newsweek, in collaboration with market research partner Statista, is proud to introduce our second annual listing of the Most Trustworthy Companies in America. This year we've listed 700 U.S. companies in 23 industries according to their evaluations by U.S. customers, employees and investors.

11: Health Care & Life Sciences / Quest Diagnostics / New Jersey / Public Company

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among patients by making the testing more accessible. Its Advanced Specialized Transplant Services now include customized educational resources for patients, expedited transport and processing of tests and 5,000 mobile phlebotomists for at-home specimen collection.

Times like these demonstrate the importance of the health care industry to New Jersey’s economy. The sector’s impact has been well documented in dollar terms over the years and officials at levels profess to recognize the critical role health care companies play – not only in providing care but also keeping the state in business. This year’s Health Care Power 50 list reflects another side of the economic story.

Quest Diagnostics on Wednesday announced support for a new program with Sesame Workshop, the nonprofit educational organization behind “Sesame Street.” The resources launched aim to address health and well-being inequities among young children, particularly in low-income, rural and marginalized communities.

Quest Diagnostics has introduced two Post-COVID-19 panels for consumers that offer information about lingering health issues associated with previous COVID-19 virus infections.

Doctors and drug companies are also warming to the medical possibilities of ceramides. Later this year, lab testing giant Quest Diagnostics will start to offer the analysis, potentially making it available to many more patients.

Diagnosing Alzheimer’s disease before symptoms develop may soon be as simple as getting a blood test. New blood tests for certain biomarkers show promise, providing physicians an alternative to expensive scans or invasive spinal taps to make a diagnosis. Quest AD-Detect: Introduced by Quest Diagnostics, this blood test also measures beta-amyloid proteins in your blood to determine your risk for developing Alzheimer’s disease. It does not determine if you have any genetic biomarkers for the disease. The test became available in May 2022, with a cost of $500. There is limited coverage by some health plans.

Although automation and artificial intelligence have long been recognized as a way to improve operational efficiency in clinical laboratories, an industry-wide staffing shortage is creating an added motivation to incorporate more technology. At Secaucus-based Quest Diagnostics, it’s just one of many market forces that is shaping the company’s post-pandemic business strategy.

Medical testing center operator Quest Diagnostics Inc. said that it has begun using a highly automated microbiology lab system that leverages AI to analyze samples. CEO Jim Davis mentioned the platform in the company’s earnings call when he was talking about ways in which it’s trying to counter “significant inflation and wage pressures.”

Do you know your blood type? There’s a good chance that you don’t. More Americans know their horoscope sign (66 percent) than their blood type (51 percent), according to a survey published this year by laboratory company Quest.